Sanofi (SASY.PA)

Sanofi (SASY.PA) Trading on MT5 at XM

At XM we offer Sanofi (SASY.PA) stocks as cash CFDs. Our cash CFDs stocks are undated transactions that aim to replicate the cash price of the underlying stock, and so they are adjusted for any relevant corporate actions.

Open a Demo Account
Open an Account

Risk warning: FX and CFD trading involves a high risk of loss.

About Sanofi (SASY.PA) Trading

Sanofi S.A. is a multinational pharmaceutical company founded in 2014 and with its headquarters in Gentilly, France. The company features as its main products and services the research, development and manufacturing of over-the-counter medicine in several major therapeutic areas such as diabetes, oncology, cardiovascular, and internal diseases. It is the largest producer of vaccines in the world.

Sanofi S.A is a Euro Stoxx 50 component. Its stock, SASY.PA, is traded on the Paris Stock Exchange.

Trading Conditions

Margin requirement 10 %
Spreads as low as 0.33
Symbols Sanofi
Description Sanofi
Min. Price Fluctuation 0.01000
Value of Minimum Price Fluctuation EUR 0.1
Value of 1 lot 10 Shares
Min/Max Trade Size 0.6/98
Swap Value in Margin Currency Long -2.44 %
Swap Value in Margin Currency Short -3.56 %
Limit and Stop Levels** 0.04
Total Volume Limit (per client)*** 976
Weekday 10:10-18:25 (GMT +3)
Monday Open 10:10 (GMT +3)   │   Friday Close 18:25 (GMT +3)
** Min. level for placing pending orders at a current market price.

*** Note that the maximum trading volume for Sanofi per client is 976 lots. This limit will be reviewed on a daily basis and updated according to the value of the instrument.

How to Start Trading Sanofi (SASY.PA)?

Step 1

Open an XM Real Account

Step 2

Download and login to the MT5 platform

Step 3

Double-click on Sanofi (SASY.PA) from the “Market Watch” to open an order for this instrument.

We are using cookies to give you the best experience on our website. Read more or change your cookie settings.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.